SCHEDULE 13G/A: T. Rowe Price Associates Reports 1.3% Passive Stake in CARGO THERAPEUTICS INC

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, disclosing a 1.3% beneficial ownership stake in CARGO THERAPEUTICS INC as of March 31, 2025.

Summary

• T. Rowe Price Associates, Inc. (TRPA) has filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in CARGO THERAPEUTICS INC.
• As of March 31, 2025, TRPA beneficially owns 597,682 shares of CARGO THERAPEUTICS INC's common stock.
• This ownership represents 1.3% of the total class of securities.
• TRPA holds sole voting power over 595,998 shares and sole dispositive power over 597,682 shares.
• TRPA is classified as an investment adviser (IA) for the purpose of this filing.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment about the issuer's performance or prospects. It simply reports an institutional investor's stake.

Future Outlook

NA

Industry Context

This filing indicates a passive investment by a major institutional asset manager, T. Rowe Price Associates, Inc., in CARGO THERAPEUTICS INC. Such filings are routine disclosures of significant ownership stakes by institutional investors, reflecting their portfolio allocations rather than specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and trading activity.

Key Dates

Keywords

CARGO THERAPEUTICS INC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Adviser